A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study

被引:3
|
作者
Sheehan, Rory [1 ]
Strydom, Andre [2 ]
Marston, Louise [3 ]
Morant, Nicola [1 ]
Fiori, Federico [4 ]
Santosh, Paramala [5 ]
Hassiotis, Angela [1 ]
机构
[1] UCL, Div Psychiat, London, England
[2] Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London, England
[3] UCL, Res Dept Primary Care & Populat Hlth, London, England
[4] Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England
[5] Kings Coll London, Dept Child & Adolescent Psychiat, London, England
来源
BMJ OPEN | 2019年 / 9卷 / 12期
基金
美国国家卫生研究院;
关键词
CHALLENGING BEHAVIOR; PEOPLE; PREVALENCE; MANAGEMENT; PATIENT; IMPACT;
D O I
10.1136/bmjopen-2019-033827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To investigate the feasibility of delivering structured psychotropic medication review in community services for adults with intellectual disability (ID). Design Single-arm feasibility study conducted over a 6-month period. Setting Specialist community ID teams in England. Participants Psychiatrists working with adults with ID and adults with ID who had been prescribed psychotropic medication. Intervention A structured web-based psychotropic medication review tool (the HealthTracker-based structured medication review) comprising measures of therapeutic benefit and adverse side-effects was made available for use by psychiatrists in routine clinic appointments. A summary measure of medication effectiveness was graphically presented to aid discussion and decision-making. Main outcome measures Feasibility metrics including number of people with ID referred, eligible and recruited, and uptake of the medication review tool in naturalistic clinical settings. Psychiatrist and patient feedback was collected to assess acceptability of the intervention and suggestions for development. Results Fifteen psychiatrists from five clinical teams took part. In total 94 potentially eligible people with ID were referred, of whom 79 (84%) were recruited and together underwent 97 medication reviews over the 6-month study period. Feedback from participants with ID was favourable. Psychiatrists indicated that the HealthTracker-based structured medication review was broadly acceptable and suggested adaptations to improve integration with existing information technology systems and to enhance patient involvement in the review. Conclusions Structured psychotropic medication review can be used in community services for adults with ID as part of a programme of medication optimisation. It would be feasible to test clinical and patient outcomes of the HealthTracker-based medication review in a randomised clinical trial.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The use of psychotropic medication for the management of problem behaviours in adults with intellectual disabilities living in Canada
    Bradley, Elspeth
    Cheetham, Thomas
    ADVANCES IN MENTAL HEALTH AND INTELLECTUAL DISABILITIES, 2010, 4 (03) : 12 - 26
  • [42] The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review
    Deb, S.
    Chaplin, R.
    Sohanpal, S.
    Unwin, G.
    Soni, R.
    Lenotre, L.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2008, 52 : 107 - 113
  • [43] Effectiveness of antipsychotic medication in people with intellectual disability and schizophrenia: a systematic review
    Duggan, L
    Brylewski, J
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1999, 43 : 94 - 104
  • [44] Factors associated with use of medication for behavioral challenges in adults with intellectual and developmental disability
    Erickson, Steven R.
    Houseworth, James
    Esler, Amy
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2022, 123
  • [45] Factors contributing to antihypertensive medication adherence among adults with intellectual and developmental disability
    Resciniti, Nicholas, V
    Hong, Yuan
    McDermott, Suzanne
    JOURNAL OF INTELLECTUAL DISABILITIES, 2022, 26 (01) : 137 - 148
  • [46] The effects of training on the ability of adults with an intellectual disability to give informed consent to medication
    Ferguson, L.
    Murphy, G. H.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2014, 58 (09) : 864 - 873
  • [47] The use of medication to manage behaviour problems in adults with an intellectual disability: a national guideline
    Unwin, Gemma L.
    Deb, Shoumitro
    ADVANCES IN MENTAL HEALTH AND INTELLECTUAL DISABILITIES, 2010, 4 (03) : 4 - 11
  • [48] Exploring Psychotropic Medication Use in Hospitalized Children With Autism Spectrum Disorder in China: The Role of Intellectual Disability
    Li, Wenqing
    Bao, Chenxi
    Ye, Yupei
    Liu, Qingxiang
    Chu, Kangkang
    Wang, Ya
    Ruan, Xiaoyan
    Lu, Huimin
    Liu, Xi
    Ke, Xiaoyan
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2025,
  • [49] Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability
    Christian, L
    Snycerski, SM
    Singh, NN
    Poling, A
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1999, 43 : 88 - 93
  • [50] STUDY ON THE USE OF ANTIPSYCHOTIC MEDICATION IN AN INTELLECTUAL DISABILITY (ID) COMMUNITY CASELOAD
    Thalitaya, Madhusudan Deepak
    Reynolds, Claire
    Ismail, Imadeldin
    PSYCHIATRIA DANUBINA, 2017, 29 : S578 - S583